151 related articles for article (PubMed ID: 17386047)
1. Dynamic staging and risk factor scoring for gestational trophoblastic disease.
Kohorn EI
Int J Gynecol Cancer; 2007; 17(5):1124-30. PubMed ID: 17386047
[TBL] [Abstract][Full Text] [Related]
2. Correlation of risk categorization in gestational trophoblastic tumor between old and new combined staging and scoring system.
Tocharoenvanich S; Chichareon S; Wootipoom V; Bu-ngachat R; Piyananjarassri K
J Obstet Gynaecol Res; 2003 Feb; 29(1):20-7. PubMed ID: 12696623
[TBL] [Abstract][Full Text] [Related]
3. Trophoblastic disease.
Ngan HY; Kohorn EI; Cole LA; Kurman RJ; Kim SJ; Lurain JR; Seckl MJ; Sasaki S; Soper JT
Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 2():S130-6. PubMed ID: 22999504
[No Abstract] [Full Text] [Related]
4. [Clinical and radiological features of gestational trophoblastic tumors].
Mamouni N; Boumhaoued S; Erraghay S; Boubou M; Bouchikhi C; Banani A
Pan Afr Med J; 2017; 28():228. PubMed ID: 29629014
[TBL] [Abstract][Full Text] [Related]
5. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia.
Ngan HY
Int J Gynecol Cancer; 2004; 14(2):202-5. PubMed ID: 15086715
[TBL] [Abstract][Full Text] [Related]
6. Understanding and management of gestational trophoblastic disease.
Ning F; Hou H; Morse AN; Lash GE
F1000Res; 2019; 8():. PubMed ID: 31001418
[TBL] [Abstract][Full Text] [Related]
7. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment.
Kohorn EI
Int J Gynecol Cancer; 2001; 11(1):73-7. PubMed ID: 11285037
[TBL] [Abstract][Full Text] [Related]
8. Can Ki67 and Caspase Predict Molar Progression?
Nagib RM; M A Zaki M; Wageh A; Abdelrazik M
Fetal Pediatr Pathol; 2019 Oct; 38(5):444-448. PubMed ID: 31038005
[No Abstract] [Full Text] [Related]
9. Short tandem repeats genotyping of gestational choriocarcinoma - our experiences.
Gergely L; Repiska V; Petrovic R; Korbel M; Danihel L; Sufliarsky J; Kubickova M; Gbelcova H; Priscakova P
Taiwan J Obstet Gynecol; 2024 Jan; 63(1):73-76. PubMed ID: 38216273
[TBL] [Abstract][Full Text] [Related]
10. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?
Sun SY; Melamed A; Goldstein DP; Bernstein MR; Horowitz NS; Moron AF; Maestá I; Braga A; Berkowitz RS
Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351
[TBL] [Abstract][Full Text] [Related]
11. Understanding gestational trophoblastic disease: How nurses can help those dealing with a diagnosis.
Bess KA; Wood TL
AWHONN Lifelines; 2006; 10(4):320-6. PubMed ID: 16911265
[No Abstract] [Full Text] [Related]
12. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
13. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.
Gockley AA; Joseph NT; Melamed A; Sun SY; Goodwin B; Bernstein M; Goldstein DP; Berkowitz RS; Horowitz NS
Am J Obstet Gynecol; 2016 Sep; 215(3):334.e1-6. PubMed ID: 27130239
[TBL] [Abstract][Full Text] [Related]
14. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
[TBL] [Abstract][Full Text] [Related]
15. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of treatment relating to gestational trophoblastic tumor registered to the French Trophoblastic Disease Reference Center (TDRC) in Lyon from 1999 to 2005].
Golfier F; Labrousse C; Frappart L; Mathian B; Guastalla JP; Trillet-Lenoir V; Hajri T; Schott AM; Raudrant D
Gynecol Obstet Fertil; 2007 Mar; 35(3):205-15. PubMed ID: 17336125
[TBL] [Abstract][Full Text] [Related]
17. Correlation between clinical staging (FIGO) and prognostic groups with gestational trophoblastic disease.
Smith DB; Holden L; Newlands ES; Bagshawe KD
Br J Obstet Gynaecol; 1993 Feb; 100(2):157-60. PubMed ID: 8386542
[TBL] [Abstract][Full Text] [Related]
18. Gestatational trophoblastic disease: multimodality imaging assessment with special emphasis on spectrum of abnormalities and value of imaging in staging and management of disease.
Kani KK; Lee JH; Dighe M; Moshiri M; Kolokythas O; Dubinsky T
Curr Probl Diagn Radiol; 2012; 41(1):1-10. PubMed ID: 22085657
[TBL] [Abstract][Full Text] [Related]
19. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
Worley MJ; Joseph NT; Berkowitz RS; Goldstein DP
Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
[TBL] [Abstract][Full Text] [Related]
20. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K
J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
